Simplex Trading, LLC Xencor Inc Transaction History

Simplex Trading, LLC

  • $2.81 Billion
  • Q3 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024
SELL
$18.65 - $26.52 $1,846 - $2,625
-99 Reduced 20.54%
383 $8,000
Q4 2023

Feb 02, 2024
SELL
$16.53 - $21.42 $5,223 - $6,768
-316 Reduced 39.6%
482 $10,000
Q3 2023

Nov 01, 2023
BUY
$20.08 - $25.39 $16,023 - $20,261
798 New
798 $16,000
Q1 2023

Apr 27, 2023
BUY
$25.95 - $36.95 $8,278 - $11,787
319 Added 5316.67%
325 $9,000
Q4 2022

Feb 02, 2023
SELL
$24.79 - $30.86 $53,595 - $66,719
-2,162 Reduced 99.72%
6 $0
Q3 2022

Nov 04, 2022
BUY
$24.62 - $32.44 $53,376 - $70,329
2,168 New
2,168 $56,000
Q1 2022

May 02, 2022
SELL
$26.68 - $41.63 $3,735 - $5,828
-140 Closed
0 $0
Q4 2021

Feb 23, 2022
SELL
$33.67 - $43.44 $5,084 - $6,559
-151 Reduced 51.89%
140 $5,000
Q2 2021

Aug 12, 2021
BUY
$34.33 - $44.68 $9,990 - $13,001
291 New
291 $10,000
Q1 2020

Apr 29, 2020
SELL
$20.69 - $37.79 $5,379 - $9,825
-260 Closed
0 $0
Q4 2019

Feb 05, 2020
BUY
$32.75 - $41.43 $8,515 - $10,771
260 New
260 $8,000
Q2 2019

Jul 26, 2019
SELL
$29.6 - $40.93 $1,361 - $1,882
-46 Closed
0 $0
Q1 2019

Apr 18, 2019
SELL
$27.85 - $38.09 $6,321 - $8,646
-227 Reduced 83.15%
46 $0
Q4 2018

Jan 16, 2019
SELL
$32.39 - $42.05 $4,372 - $5,676
-135 Reduced 33.09%
273 $9,000
Q3 2018

Oct 23, 2018
BUY
$35.69 - $47.65 $14,561 - $19,441
408 New
408 $15,000

Others Institutions Holding XNCR

# of Institutions
215
Shares Held
71.5M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.43B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email